European, multicentre, single arm (phase I) trial of autologous skeletal muscle derived cell (ASMDC) microcarrier combination for the treatment of faecal incontinence (FI) in women with obstetric anal sphincter injury.

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504282-23-00

Acronym

AMELIE

Enrollment

Registered

2025-10-28

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Faecal incontinence

None listed

Sex/Gender

All

Age

18 Years to No maximum

Austria, Denmark, France, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026